Latest News

A small number of people report chronic symptoms after receiving COVID-19 shots. A new study provides clues for further research.

Yale School of Medicine, the Department of Genetics, Yale New Haven Health, and the National Organization for Rare Disorders are hosting a Rare Disease Celebration on Friday, Feb. 21 from 1 – 5 p.m. at the Greenberg Conference Center.

Marco Galimberti, PhD, postdoctoral associate, and Joel Gelernter, MD, Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience, are first and senior authors, respectively, of a paper on Molecular Psychiatry that investigates the genetic architecture and causal relationships between cannabis use disorder and lifetime cannabis use with risk for developing substance use disorders and substance use traits.

Yale Cancer Center researcher, Dr. Smita Krishnaswamy, discusses her new study understanding where tumors start and if treatment drives them towards chemo-resistance and chemo-sensitivity, potentially helping predict prognosis for patients.

A collection of recent studies from YSM

New research is revealing that endometriosis is not just a gynecologic disease, but rather a widespread inflammatory disorder.

An openness to collaboration is just one factor in the popularity of team science at YSM.

Yale School of Medicine's Department of Pathology has entered the booming field of digital pathology.

If the human genome is like the blueprint for a house, a new study on the non-coding parts of DNA maps the wiring—connecting the lights to their switches.